$0.9650
-0.00500-0.52%
At close: -
$0.9271
-0.04-3.93%
After Hours: May 27, 8:44 AM EDT
Comments
Loading...
Channel Therapeutics Earnings Estimates, EPS & Revenue | AMEX:CHRO | Benzinga
Channel Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS
$-0.320
Quarterly Revenue
$0.00
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Channel Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHRO | Chromocell Therapeutics | -$0.31 | — | — | — | $0.00 | — | — | — | 08/12/2025 | Get Alert |
| CHRO | Chromocell Therapeutics | -$0.55 | -$0.29 | -$0.32 | -10.34% | $0.00 | — | $0.00 | — | 05/13/2025 | Get Alert |
| CHRO | Chromocell Therapeutics | — | -$0.21 | -$0.32 | -52.38% | — | — | $0.00 | — | 03/27/2025 | Get Alert |
| CHRO | Chromocell Therapeutics | -$1.44 | -$0.55 | -$0.29 | 47.27% | $0.00 | — | $0.00 | — | 11/13/2024 | Get Alert |
| CHRO | Chromocell Therapeutics | -$0.95 | — | -$0.31 | — | $0.00 | — | $0.00 | — | 08/13/2024 | Get Alert |
| CHRO | Chromocell Therapeutics | -$0.87 | — | -$0.55 | — | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
Channel Therapeutics (CHRO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-13 | $-0.32 | $-0.29 | -10.3 % |
| Q4 | 2025-03-27 | $-0.32 | $-0.21 | -52.4 % |
| Q3 | 2024-11-13 | $-0.29 | $-0.55 | 47.3 % |
Channel Therapeutics (CHRO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Channel Therapeutics (AMEX:CHRO) reporting earnings?
Channel Therapeutics (CHRO) is scheduled to report earnings on August 12, 2025. The last reported earnings were for reported on May 13, 2025 for Q1.
What were the latest earnings per share (EPS) for Channel Therapeutics (AMEX:CHRO)?
The Actual EPS was $-0.32, which missed the estimate of $-0.29.
What were Channel Therapeutics’s (AMEX:CHRO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
